. Proteomic Identification of 6AzGlcNAc-labeled proteins! ! ! Page S21 Table S2 . Proteomic Identification of GlcNAz-labeled proteins! ! ! Page S31 Table S2 Ac4GlcNAz is accepted by these enzymes and is ultimately transformed into the UDP donor sugar the which is utilized by OGT to modify protein substrates. (B) 6AzGlcNAc cannot be phosphorylated at the 6-position by GNK. We demonstrate that 6AzGlcNAc can be directly transformed to 6AzGlcNAc-1-phosphate by AGM1 and subsequently transformed to UDP-6AzGlcNAc by AGX1. Figure S3 . Galactosamine kinase (GalK2) knockdown. Cell-lines with stable knockdown (shRNA) of GalK2 were treated with 6AzGlcNAc (200 μM) for 16 hours before visualization by in-gel fluorescence.
Extrait d'ion correspondant au composé phosphorylé (isotope le plus intense de l'ion dichargé).
Extraction of the ions corresponding to the phosphorylated compound (most intense isotope of the double-charged ion)
X014864CYC.d 
PGM3 + 6 azidoGlcNAc + GlcNAc6P
PGM3 + 6 azidoGlcNAc + GlcP6P PGM3 + 6 azidoGlcNAc + Glc1,6diP Figure S4 . LC-MS analysis of 6AzGlcNAc-1-phosphate production by AGM1. AGM1 enzymatic reactions were subjected to copper-free click chemistry with bicyclooctyn-POE3-fluorescein and subjected to separation by paper chromatography. Fluorescent spots were eluted and analyzed using LC-ESI-MS. Ions corresponding to the fluorescein-conjugated 6AzGlcNAc-1-phosphate (most intense isotope of the double-charged ion) were extracted (blue trace). Only in the presence of AGM1 (PGM3) and GlcNAc-6-phosphate is the formation of 6AzGlcNAc-1-phosphate observed. Units on the y-axis are not uniform. 
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Figure S14. 9) Figure S15. 9) Supplementary Table 1 . Proteins identified using 6AzGlcNAc enrichment. NIH 3T3 were treated in triplicate with either Ac36AzGlcNAc (200 µM, +) or Ac4Glc-NAc (200 µM, -) for 16 hours. At this time the cell lysates were subjected to CuAAC with alkyne-biotin, followed by enrichment with streptavidin beads and onbead trypsinolysis. Labeled proteins were selected as those that were represented by at least 1 unique-peptide in each Ac36AzGlcNAc treated sample, a total of at least 3 spectral-counts from the same three samples, and at least a total of 3 times more spectral counts in the Ac36AzGlcNAc treated samples compared to Ac4Glc-NAc. Blue indicates proteins previously identified in O-GlcNAc proteomic studies, purple indicates proteins identified in both O-GlcNAc and mucin O-linked proteomic studies and red indicates proteins identified in only O-linked mucin proteomic studies. Novel proteins that were identified in this study are indicated in white.
No .
6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 
Q9JLV1 BAG3 BAG family molecular chaperone regulator 3 0 9 0 9 0 10 0 28 N/A 9.679E-06 61.8 ✓ ✓ ✓ 
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6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc 6AzGlcNAc Table 2 . Proteins identified using GlcNAz enrichment. NIH 3T3 were treated in triplicate with either Ac4GlcNAz (200 µM, +) or Ac4GlcNAc (200 µM, -) for 16 hours. At this time the cell lysates were subjected to CuAAC with alkyne-biotin, followed by enrichment with streptavidin beads and on-bead trypsinolysis. Labeled proteins were selected as those that were represented by at least 1 unique-peptide in each Ac4GlcNAz treated sample, a total of at least 3 spectral-counts from the same three samples, and at least a total of 3 times more spectral counts in the Ac4GlcNAz treated samples compared to Ac4GlcNAc. Blue indicates proteins previously identified in O-GlcNAc proteomic studies, purple indicates proteins identified in both O-GlcNAc and O-linked mucin proteomic studies and red indicates proteins identified in only O-linked mucin proteomic studies. Novel proteins that were identified in this study are indicated in white.
GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz 
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No.
S32
S33
GlcNAz 
S34
S35
No. 
GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz
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GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz GlcNAz
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Supplementary Table 3 . Proteins identified using GalNAz enrichment. NIH 3T3 were treated in triplicate with either Ac4GalNAz (200 µM, +) or Ac4GlcNAc (200 µM, -) for 16 hours. At this time the cell lysates were subjected to CuAAC with alkyne-biotin, followed by enrichment with streptavidin beads and on-bead trypsinolysis. Labeled proteins were selected as those that were represented by at least 1 unique-peptide in each Ac4GalNAz treated sample, a total of at least 3 spectral-counts from the same three samples, and at least a total of 3 times more spectral counts in the Ac4GalNAz treated samples compared to Ac4GlcNAc. Blue indicates proteins previously identified in O-GlcNAc proteomic studies, purple indicates proteins identified in both O-GlcNAc and O-linked mucin proteomic studies and red indicates proteins identified in only O-linked mucin proteomic studies. Novel proteins that were identified in this study are indicated in white.
GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz (1)(2)(9)(13)(19 ) (20)(21)(22)(2 3) (24)(26) Q80X50 - GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz 2 6) (17) G3UWA6 G3UWA6 
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GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz (23) Q501J7 - 
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GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz GalNAz 
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